| Helvepharm AG - Candesartan HCT Zentiva 8/12.5mg, Tabletten |
| 62321 | | 01 | | Candesartan HCT Zentiva 8/12.5mg | | Tabletten | | C09DA06 | | Candesartan und Diuretika | | 30.01.2012 | | |
|
| Composition |
| candesartanum cilexetilum 8 mg, hydrochlorothiazidum 12.5 mg, maydis amylum, lactosum monohydricum 117.3 mg, triethylis citras, hydroxypropylcellulosum, carmellosum natricum conexum corresp. natrium 0.36 mg, magnesii stearas, pro compresso. |
| Packungsbestandteile |
| Comprimés | | | | | Principe actif | Concentr. |
|---|
| Candesartanum Cilexetil | 8 mg | | Hydrochlorothiazide | 12.5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Candesartanum Cilexetil | 8 mg | | Hydrochlorothiazide | 12.5 mg |
| | | | Agents auxilliaires | Concentr. |
|---|
| Carmellosum Natricum Conexum | | | Hydroxypropylcellulosum | | | Lactose Monohydrate | 117.3 mg | | Magnesii Stearas | | | Maydis Amylum | | | Pro Compresso | | | Triethylis Citras | |
| |
|
|
